Dr. Albers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 Parkman Street
Wacc 830
Boston, MA 02114Phone+1 617-726-1728Fax+1 617-726-4101
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1997 - 2000
Massachusetts General HospitalResidency, Internal Medicine, 1995 - 1997
Harvard Medical SchoolClass of 1995
Certifications & Licensure
MA State Medical License 2007 - 2026
NY State Medical License 2000 - 2008- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2 Start of enrollment: 2022 Nov 14
Roles: Principal Investigator, Contact
- Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD Start of enrollment: 2023 May 09
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 106 citationsMachine learning identifies candidates for drug repurposing in Alzheimer's disease.Steven Rodriguez, Clemens B. Hug, Petar Todorov, Nienke Moret, Sarah A. Boswell
Nature Communications. 2021-02-15 - 428 citationsInhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity.Jun O. Liu, Mark W. Albers, Thomas J. Wandless, Sheng Luan, D. G. Alberg
Biochemistry. 1992-04-28 - 1530 citationsA mammalian protein targeted by G1-arresting rapamycin–receptor complexEric J. Brown, Mark W. Albers, Tae Bum Shin, Kazuo ichikawa, Curtis Keith
Nature. 1994-06-30
Press Mentions
Long Covid Could Reveal Clues to Alzheimer’s, Lyme DiseaseMarch 17th, 2022- AI and Alzheimer's DiseaseMarch 4th, 2021
- Engaging AI in the Battle Against Alzheimer’sMarch 4th, 2021
- Join now to see all
Grant Support
- The Olfactory Neural Circuit As A Systems Level Model Of Neurodegenerative DiseasOffice Of The Director, National Institutes Of Health2009
- Mapping Molecular And Cellular Responses To OdorantsNational Institute On Deafness And Other Communication Disorders2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
